Michael W. Bonney, Director at Sarepta Therapeutics, Inc. (SRPT), bought 2,000 shares at $86.74 ($173K) on 2019-09-09, disclosed to the SEC on 2019-09-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALNY | SELL | 2023-12-29 | $5.8M | — | Filing → |
| ALNY | SELL | 2023-08-04 | $2.2M | — | Filing → |
| BMY | BUY | 2020-06-09 | $5K | — | Filing → |